Shattuck Labs Announces Drug Discovery Collaboration With Ono Pharmaceutical, For Bifunctional Fusion Proteins Targeting Certain Autoimmune And Inflammatory Disease Pathways, Shattuck To Receive Upfront And Be Eligible For Milestone Payments Of Upto $227M
Shattuck Labs宣布与小野制药合作开发靶向某些自身免疫和炎症性疾病途径的双功能融合蛋白,Shattuck将获得预付款,并有资格获得高达2.27亿美元的里程碑式付款